Altium Capital Management LLC / AKRO
Altium Capital Management LLC’s Akero Therapeutics Inc Com Position
Does Altium Capital Management LLC own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 125.0K shares worth $7M in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$7M
Q4 2022
Shares
125.0K
% of Portfolio
+3.48%
Quarters Held
2
position exited
Position History AKRO
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of AKRO.